CDRH Unveils Postmarket Safety “Action Items”
This article was originally published in The Gray Sheet
Executive Summary
FDA's plan to strengthen postmarket device safety by making better use of postmarket data includes modifying its organizational infrastructure, updating adverse event reporting practices and potentially increasing the use of fines for certain types of industry noncompliance
You may also be interested in...
Scrapping The Matrix: CDRH Seeks Alternative Approach To Breaking Silos
Two years after going live, CDRH's "matrix," a structure of network leaders tasked with keeping pre-market and post-market offices communicating, is likely on its way out
Scrapping The Matrix: CDRH Seeks Alternative Approach To Breaking Silos
Two years after going live, CDRH's "matrix," a structure of network leaders tasked with keeping pre-market and post-market offices communicating, is likely on its way out
Electronic Adverse Event Reporting Would Be Mandatory Under FDA Proposal
Device manufacturers would have to submit adverse event reports to FDA electronically under a draft rule issued Aug. 20